BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu X, Cheng L, Fu M, Huang B, Zhu L, Xu S, Shi H, Zhang D, Yuan H, Nawaz W, Yang P, Hu Q, Liu Y, Wu Z. A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration.. [DOI: 10.1101/2021.02.08.429275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Wang Y, Cheng L, Ni F, Zhu L, Ma S, Huang B, Ji M, Hu H, Li Y, Xu S, Shi H, Zhang D, Liu L, Nawaz W, Hu Q, Ye S, Liu Y, Wu Z. Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22). Front Immunol 2022;13:865401. [DOI: 10.3389/fimmu.2022.865401] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wu X, Wang Y, Cheng L, Ni F, Zhu L, Ma S, Huang B, Ji M, Hu H, Li Y, Xu S, Shi H, Zhang D, Liu L, Nawaz W, Hu Q, Ye S, Liu Y, Wu Z. Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22).. [DOI: 10.1101/2021.09.06.459055] [Reference Citation Analysis]